Global Scleral Lens Market TOC
Scleral Lens Market size is estimated to reach USD 870 Million by the end of 2035, growing at a CAGR of 8.15% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of scleral lens was USD 310 Million. The growth of the market is anticipated by the growing demand for scleral lenses that has increased across many countries in part because of the rising prevalence of vision problems such as keratoconus and dry eye syndrome. These lenses are a favored option for people with difficult corneal conditions across various age groups because they offer better comfort, stability, and visual acuity than regular contact lenses. Of every 100,000 people, keratoconus affects between 50 and 200.
Furthermore, the development of advanced materials and designs, such as silicone hydrogel lenses and orthokeratology, has led to increased worldwide use of contact lenses, including scleral lenses. The availability of specialized scleral lens designs, such as those for myopia management and irregular cornea management, has further expanded the market and catered to specific patient needs. According to the recent review, scleral lens prescriptions accounted for over 2% of the total contact lens market in 2021. In the gas permeable (GP) lens market, scleral lens use increased from 14% in 2021 to 21% in 2022.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
8.15% |
|
Base Year Market Size (2022) |
USD 310 Million |
|
Forecast Year Market Size (2035) |
USD 870 Million |
|
Regional Scope |
|
Type (Mini-Scleral Lenses, Corneo-Scleral Lenses and Semi-Scleral, Full-Scleral Lenses)
The full-scleral lenses segment in the scleral lens market is the largest and is expected to reach USD 350 million by 2035, rising at a substantial CAGR of 7.89% between 2022 and 2035. In 2022, the segment was worth USD 130 million. The complete scleral lens is the greatest variety of scleral lens. It provides the greatest coverage between the cornea and the rear surface of the lens. A complete scleral lens is utilized in cases of severe ocular illness, extreme dry eyes, or advanced keratoconus. When the cornea is injured or distorted, conventional contact lenses and eyeglasses frequently cannot restore visual acuity (irregular). The cornea is covered by bigger lenses called sclera. The sclera, or white part of the eye, supports it. There is a moist bed covering the cornea. Excellent comfort and vision are offered by this. This segment is anticipated given the rising occurrence of corneal abnormalities. As per the World Health Organization, 1.9 million individuals suffer from corneal blindness as a result of corneal opacification, making up around 5% of all blind patients.
Application (Keratoconus, Astigmatism, Dry Eyes, Giant Papillary Conjunctivitis (GPC), Post-Refractive Surgery, Presbyopia, Stevens-Johnson syndrome, Eyelid coloboma, Athletes)
The keratoconus segment in the scleral lens market was assessed at USD 0.11 billion in 2022 and is expected to have a value of USD 310 million by 2035, rising at a substantial CAGR of 8.77% over the projected time frame. Glasses cannot fit the irregular, cone-shaped corneas of keratoconus patients, and as a result, they cannot effectively correct their vision. The best option is to utilize scleral contact lenses, which sit on the sclera without touching the cornea and, in most situations, offer optimum clarity while staying fully comfortable. Many optometrists and ophthalmologists advise scleral contact lenses for a range of hard-to-fit eye conditions, such as keratoconus eyes. In instances of early keratoconus, a regular GP lens may be utilized. On the other hand, employing a large-diameter scleral contact lens could be the solution if the lens is uncomfortable and does not center on the eye or move significantly with blinks.
Our in-depth analysis of the global scleral lens market includes the following segments:
|
Type |
|
|
Application |
|
North American Market Forecast
The scleral lens market in North America is projected to be the largest with the largest revenue of USD 310 million by the end of 2035 by growing at a CAGR of 7.97% over the forecast period. Due to the expansion of well-known manufacturers' product lines and the rise in the number of scleral lens patients, North America is expected to earn a substantial portion of the market share for scleral lenses. Furthermore, the number of eye disorders in the region is rising, and leading companies are working together more closely to support the market's expansion. Refractive vision diseases affect a sizable segment of the patient population in North America, particularly in the US. This adds to the area's significant market share, along with easier access to eye care services. Additionally, there is an increase in demand for scleral lenses as a result of customers becoming more aware of their advantages. 2.3 million Americans are blind today, and by 2030, that number is predicted to rise to 2.2 million. Five million Americans are expected to have reduced eyesight by 2030, up from the current 2.9 million.
APAC Market Statistics
The Asia Pacific scleral lens market is estimated to be the second-largest by developing at a CAGR of 9.47% in the given time frame. The Asia Pacific market is expected to be worth USD 250 million by the end of 2035, up from USD 78.65 million in 2022. The Asia Pacific region's growing patient base for radial keratotomy and post-LASIK operations has increased demand for sophisticated eye care products, such as scleral lenses. After these refractive operations, patients may have better vision and comfort with scleral lenses. The Asia Pacific area has seen a rise in the use of scleral lenses as a result of patients' and eye care professionals' growing understanding of their advantages.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?